在胸前大动脉手术患者中,MELD评分和查尔森并发症指数的预测值
Ismail Dalyanoglu1, Freya Sophie Jenkins2, Luis Jaime Vallejo Castano2
1Sankt Marien Hospital Gelsenkirchen-Buer, 45894 Gelsenkirchen, Germany.
Journal of cardiovascular development and disease
|December 24, 2025
概括
末期肝病- (MELD-Na) 模型得分有效预测经过胸前动脉瘤手术的患者的死亡率,优于其他风险得分. 这有助于选择性上升大动脉手术患者的手术前风险分层.
科学领域:
- 心脏病学 心脏病学
- 血管外科 血管外科
- 医疗信息学 医疗信息学
背景情况:
- 胸前动脉动脉瘤 (TAA) 具有致命破裂的重大风险,需要精确的手术前风险评估.
- 现有的风险分层模型可能无法完全捕捉选择性上升大动脉手术中患者结果的复杂性.
研究的目的:
- 评估系统性风险评分的预测能力,包括末期肝病模型 (MELD) 和查尔森并发症指数 (CCI),用于医院死亡率,住院时间和接受选择性上升大动脉手术的患者的一年死亡率.
- 在这个患者队列中,将MELD变异 (MELD-Na和MELD-XI) 与标准MELD和CCI的预后性能进行比较.
主要方法:
- 对500名因上升胸前大动脉疾病而接受选择性手术的患者 (2003-2023) 的回顾性分析.
- 从手术前的实验室数据计算MELD,MELD-Na和MELD-XI得分.
- 查尔森并发症指数 (CCI) 从已记录的并发症推导;评估结果,包括住院死亡率,住院时间和一年死亡率.
主要成果:
- MELD-Na在住院死亡率 (AUC = 0.698) 和一年死亡率 (AUC = 0.732) 中显示出最强的预测能力,表现优于标准的MELD和年龄调整后的CCI.
- 查尔森并发症指数 (CCI) 显示了一年死亡率的预测值有限 (AUC = 0.509).
- 医院住院时间的预测能力在所有分数中都是温和的,年龄调整后的CCI显示了最高的歧视 (AUC = 0.627).
结论:
- MELD评分,特别是MELD-Na,是预测接受选择性上升大动脉手术的患者住院和一年死亡率的宝贵工具.
- MELD-Na和年龄调整的CCI提供了实用的术前预后信息,有助于早期分拣和个性化风险评估.
- 这些分数,由于其简单性和依赖常规数据,可以补充在手术前规划和资源分配中现有的风险模型.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
194
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
194
Mitral Stenosis II: Clinical features and Diagnostic Tests
189
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
189
Mitral Valve Prolapse II: Assessment and Management
368
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
368
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
366
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
366
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
324
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
324
Mitral Stenosis III: Medical Management
219
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
219


